Regeneron Crashes 9% After Eylea Miss Drags Its Earnings Down

investors.com/news/technology/regeneron-stock-regeneron-pharmaceuticals-earnings-q1-2025-branch

Regeneron stock tumbled Tuesday after the biotech giant reported a major revenue miss due to light sales of its eye drug Eylea.
The post Regeneron Crashes 9% After Eylea Miss Drags Its Earnings Down appeared first on Investor's Business Daily.

This story appeared on investors.com, 2025-04-29 14:37:12.
The Entire Business World on a Single Page. Free to Use →